RA — Regulatory Affairs

European Regulatory Affairs Consulting & Applications

From initial strategy development to market introduction, M.P.C.A. International provides comprehensive regulatory affairs services tailored to your exact requirements. We optimise time to market while ensuring full compliance with EU regulations.

BENELUX national procedures & European MRP/DCP
eCTD submissions via EXTEDO software
Medical translations in EN, FR, NL, DE
File adjustments for AU, USA, CA and more
25+ years Benelux regulatory expertise
Is this service for you?

Do any of these questions apply to you?

  • Are you planning for meetings with regulatory authorities?
  • Is your drug eligible for Orphan Drug status?
  • Would you like to benefit from our experience in publishing managing electronic submissions?
  • Are you an ASME looking to benefit from European government financial support?
  • Would you like to analyse your chances to meet market access requirements in the Benelux and EU?

If you answered yes to any of these, M.P.C.A. International can help. We provide the services you need with the quality you require. From initial strategy development up to market introduction.

Talk to our RA specialists

Our regulatory affairs expertise

  • QP accredited
  • RIP certified
  • 25+ years Benelux RA experience
  • National, MRP & DCP procedures
  • EXTEDO eCTD software publishing
  • Medical and technical writing & translations
  • In-house placement available
  • MPCA-online on-demand advice
Service areas

Our regulatory affairs services in detail

Our regulatory affairs services can be divided into three main areas. Each tailored to your specific needs and stage of product development.

01

Contract Regulatory Affairs

Comprehensive RA services from our offices in Ghent, covering the full range from initial strategy to market authorisation and lifecycle management.

  • Initial strategy development
  • Marketing authorisation applications & follow-up
  • Variations, notifications & renewals
  • eCTD publishing & validation (EXTEDO)
  • Medical & technical writing (SmPC, PIL)
  • Medical translations (NL, FR, DE, ENG)
  • Artwork review & PIL/labelling approval
  • Product database updates (pharmastatus, e-compendium)
  • Communication with FAMHP, CBG-MEB, Santé LU & EMA
02

In-House Placements

We recognise that many clients prefer contract regulatory staff working in their own offices for easier access to documentation and greater interaction with the project team.

  • Staff placed at your site (days/week or full-time)
  • Flexible engagement models
  • Seamless integration with your team
  • Access to M.P.C.A. expertise & network
  • Both short-term projects & long-term engagements
03

MPCA-online — on-demand advice

Some clients need ad hoc regulatory advice regularly. Our MPCA-online service gives you instant access to expert guidance. You only pay for the time it takes us to respond.

  • Submit questions by email
  • Rapid expert response
  • Pay-per-question model
  • Access to full M.P.C.A. RA expertise
  • Ideal for ad hoc regulatory queries
Benelux specialists

Deep expertise in BENELUX regulatory procedures

We are especially informed about the domestic Life Cycle Management (LCM) requirements of the Belgian, Dutch and Luxembourg authorities. Our team handles filings with FAMHP, CBG-MEB and Santé Luxembourg on a daily basis.

After market authorisation is granted, M.P.C.A. International provides complete closing-off in the BENELUX territory, including completion of national closings and submission of 'notification de modification - NOMO' in Luxembourg. Once commercialised, we support and manage your regulatory files throughout their complete life cycle.

Discuss your RA project
Regulatory authorities we work with
🇧🇪 FAMHP (Belgium)
🇳🇱 CBG-MEB (Netherlands)
🇱🇺 Santé (Luxembourg)
🇪🇺 EMA (European)
🇦🇺 Australia (TGA)
🇺🇸 USA (FDA)
Procedures
National MRP DCP Centralised Variations Renewals
Frequently asked questions

Regulatory Affairs in the Benelux

What does a Regulatory Affairs consultant do?
A Regulatory Affairs consultant guides pharmaceutical companies through the rules and procedures needed to bring a product to market and keep it there. This includes regulatory strategy, preparing and submitting marketing authorisation applications, managing variations and renewals, and ensuring ongoing compliance throughout the product lifecycle. At M.P.C.A. International we provide this support for the Belgian, Dutch and Luxembourg markets, as well as European procedures.
Which regulatory procedures can M.P.C.A. International handle?
We support national procedures for Belgium, the Netherlands and Luxembourg, as well as European procedures such as the Mutual Recognition Procedure (MRP), the Decentralised Procedure (DCP) and centralised submissions via the EMA. We handle the full marketing authorisation lifecycle, from initial dossier to variations, renewals and lifecycle management.
What is eCTD and do you prepare eCTD submissions?
eCTD (electronic Common Technical Document) is the standard electronic format for publishing or submitting regulatory dossiers to health authorities. Yes, we prepare and publish compliant eCTD submissions using validated software (EXTEDO) and we can convert existing CTD or paper dossiers into eCTD format for all EU regulatory procedures.
Do you support both human and veterinary medicinal products?
Yes. Our Regulatory Affairs services cover human and veterinary medicinal products, as well as medical devices, food supplements, cosmetics and biocides, across the full product lifecycle in the Benelux.
How do I get started with a regulatory project?
You can contact our team for a no-obligation consultation. We assess your regulatory needs, propose a tailored approach and provide a clear timeline and budget for your project in the Benelux.
Get in touch

Ready to streamline your
regulatory strategy?

Our regulatory affairs team is ready to support you - from initial strategy to market introduction and full lifecycle management - in the Benelux and beyond.